ANXA4
Annexin A4
Also known as: ANX4, ANXA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09525
- Gene
- ANXA4
- Ensembl
- ENSG00000196975
- Chromosome
- 2
- Canonical length
- 319 aa
- Protein class
- Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Annexin IV (ANX4) belongs to the annexin family of calcium-dependent phospholipid binding proteins. Although their functions are still not clearly defined, several members of the annexin family have been implicated in membrane-related events along exocytotic and endocytotic pathways. ANX4 has 45 to 59% identity with other members of its family and shares a similar size and exon-intron organization. Isolated from human placenta, ANX4 encodes a protein that has possible interactions with ATP, and has in vitro anticoagulant activity and also inhibits phospholipase A2 activity. ANX4 is almost exclusively expressed in epithelial cells. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>P09525|ANXA4
1 MATKGGTVKA ASGFNAMEDA QTLRKAMKGL GTDEDAIISV LAYRNTAQRQ EIRTAYKSTI
61 GRDLIDDLKS ELSGNFEQVI VGMMTPTVLY DVQELRRAMK GAGTDEGCLI EILASRTPEE
121 IRRISQTYQQ QYGRSLEDDI RSDTSFMFQR VLVSLSAGGR DEGNYLDDAL VRQDAQDLYE
181 AGEKKWGTDE VKFLTVLCSR NRNHLLHVFD EYKRISQKDI EQSIKSETSG SFEDALLAIV
241 KCMRNKSAYF AEKLYKSMKG LGTDDNTLIR VMVSRAEIDM LDIRAHFKRL YGKSLYSFIK
301 GDTSGDYRKV LLVLCGGDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANXA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 535 nTPM
Expression across tissuesHPA
Tissue
- gallbladder: 535 nTPM
- pancreas: 337 nTPM
- duodenum: 255 nTPM
- small intestine: 219 nTPM
- choroid plexus: 153 nTPM
- liver: 113 nTPM
Single-cell type
- cholangiocytes: 3,206 nCPM
- pancreatic duct cells: 2,704 nCPM
- syncytiotrophoblasts: 824 nCPM
- enterocytes: 683 nCPM
- extravillous trophoblasts: 625 nCPM
- cardiomyocytes: 582 nCPM
Immune cell
- basophil: 81 nTPM
- non-classical monocyte: 59 nTPM
- myeloid DC: 51 nTPM
- naive B-cell: 47 nTPM
- intermediate monocyte: 43 nTPM
- memory B-cell: 41 nTPM
Brain region
- choroid plexus: 86 nTPM
- white matter: 11 nTPM
- medulla oblongata: 9.5 nTPM
- spinal cord: 9.5 nTPM
- thalamus: 8.9 nTPM
- hypothalamus: 8.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ANXA4.
Disease | ImmuneIEDB
Conditions an epitope on ANXA4 was assayed in.
- type 1 diabetes mellitus T cell
ReferencesPubMed · IEDB
Publications for ANXA4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.
2012 · J Immunol · RCR 1.8 · 60 citations - Alteration of annexin IV expression in alcoholics.
2001 · Alcohol Clin Exp Res · RCR 0.4 · 14 citations - Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia.
2025 · J Autoimmun
Reference: T cellIEDB
1 publication
- The antigen presentation landscape of cytokine-stressed human pancreatic islets.
2025 · Cell Rep · RCR 2.5 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.86
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- epithelial cell differentiation
- negative regulation of apoptotic process
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of interleukin-8 production
- negative regulation of transcription by RNA polymerase II
- negative regulation of tumor necrosis factor-mediated signaling pathway
- Notch signaling pathway
- signal transduction
Molecular functions
- calcium ion binding
- calcium-dependent phospholipid binding
- calcium-dependent protein binding
- identical protein binding
- NF-kappaB binding
- phosphatidylserine binding
- phospholipase inhibitor activity
- transcription regulator inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANXA4 as an antibody target. Whether an autoantibody or antibody against ANXA4 could matter depends on whether native ANXA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANXA4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANXA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...